Two influential players in the 340B world have recently taken on key positions at retail pharmacy giant Walgreens, one of [...] …
Articles by : Shannon Young, Associate Editor/Senior Writer
A Japanese pharmaceutical giant and Massachusetts biotechnology company recently announced changes to their respective 340B contract pharmacy restrictions. Tokyo-based Takeda [...] …
News Alert
Stakeholders React to HELP Committee Chair Cassidy’s 340B Probe Findings, Reform Recommendations
340B hospitals, contract pharmacies, health center advocates and the drug industry offered mixed responses Thursday on the long-awaited findings and [...] …
The leader of a key U.S. Senate Committee tasked with overseeing the 340B program called Thursday for Congress to improve [...] …
While much of the focus in Washington, D.C. has been on confirmation hearings and budget matters, the 340B program continued [...] …
Editor’s Note: With 340B-related litigation heating up in several states following the enactment of new contract pharmacy access laws, 340B [...] …
The leaders of four health systems recently met with Health and Human Services (HHS) Secretary Robert F. Kennedy Jr. and [...] …
President Donald Trump’s (R) preliminary budget appears to call for “new authority to regulate all aspects of the 340B program,” [...] …
The U.S. Department of Health and Human Services (HHS) should identify and implement ways to formally coordinate activities relating to [...] …
Editor’s Note: With 340B-related litigation heating up in several states following the enactment of new contract pharmacy access laws, 340B [...] …